Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03539328
Title Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer (MITO27)
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Gemcitabine + Paclitaxel + Pegylated liposomal-doxorubicin

Gemcitabine + Paclitaxel + Pegylated liposomal-doxorubicin + Pembrolizumab

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.